In a message dated 10/11/2005 2:54:48 A.M. Central Standard Time, hiv@... writes:
NATAP http://natap.org/
_______________________________________________
TMC-114 (protease inhibitor) Expanded Access Program
Expected Initiation: Autumn 2005
Tibotec Therapeutics Expanded Access Program
1-866-889-2074 (within US) or
e-mail: TMC114-C226@... or
http://www.tibotec.com
Class Protease Inhibitor
Usual Dose TMC-114 600mg twice daily + ritonavir 100mg twice daily
Enrollment Criteria ¿É
> 18 years old
CD4+ T cell count ≤ 200 cells/mm3
--Received treatment from each of the three major classes (NNRTIs, PIs, and NRTIs) including 2 different PI-based regimens.
--Have limited or no treatment options due to virologic failure or intolerance to multiple ARV regimens.
_______________________________________________
Regards,
Nelson Vergel
Program for Wellness Restoration
Thanks
Lecture Dates:
NY Oct 12 &13 (Spanish and English),El Paso Oct 10, San Francisco Oct 25, Fort Lauderdale Oct 14, POZ Cruise- Miami- Oct 15-21, Houston Sept 29, Austin Nov 1, San Diego Nov. 3, Oaxaca Nov 28-29, Laredo Dec 7, Atlanta Dec 14,
Disclaimer
This information (and any accompanying printed material) is not intended to replace the attention or advice of a physician or other health care professional. Anyone who wishes to embark on any dietary, drug, exercise, or other lifestyle change intended to prevent or treat a specific disease or condition should first consult with and seek clearance from a qualified health care professional.